Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

A multivariate approach to predict the volumetric and gravimetric feeding behavior of a low feed rate feeder based on raw material properties.

Bostijn N, Dhondt J, Ryckaert A, Szabó E, Dhondt W, Van Snick B, Vanhoorne V, Vervaet C, De Beer T.

Int J Pharm. 2019 Feb 25;557:342-353. doi: 10.1016/j.ijpharm.2018.12.066. Epub 2018 Dec 29.

PMID:
30599227
2.

Impact of material properties and process variables on the residence time distribution in twin screw feeding equipment.

Van Snick B, Kumar A, Verstraeten M, Pandelaere K, Dhondt J, Di Pretoro G, De Beer T, Vervaet C, Vanhoorne V.

Int J Pharm. 2019 Feb 10;556:200-216. doi: 10.1016/j.ijpharm.2018.11.076. Epub 2018 Dec 11.

PMID:
30550749
3.

RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial.

Lim SH, Linton KM, Collins GP, Dhondt J, Caddy J, Rossiter L, Vadher K, Fines K, Rogers LE, Fernando D, Stanton L, Davies AJ, Johnson PWM, Griffiths G.

Trials. 2018 Nov 9;19(1):619. doi: 10.1186/s13063-018-2996-6.

4.

A multivariate raw material property database to facilitate drug product development and enable in-silico design of pharmaceutical dry powder processes.

Van Snick B, Dhondt J, Pandelaere K, Bertels J, Mertens R, Klingeleers D, Di Pretoro G, Remon JP, Vervaet C, De Beer T, Vanhoorne V.

Int J Pharm. 2018 Oct 5;549(1-2):415-435. doi: 10.1016/j.ijpharm.2018.08.014. Epub 2018 Aug 14.

PMID:
30118831
5.

Impact of blend properties on die filling during tableting.

Van Snick B, Grymonpré W, Dhondt J, Pandelaere K, Di Pretoro G, Remon JP, De Beer T, Vervaet C, Vanhoorne V.

Int J Pharm. 2018 Oct 5;549(1-2):476-488. doi: 10.1016/j.ijpharm.2018.08.015. Epub 2018 Aug 11.

PMID:
30107220
6.

VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures.

Nikitidou L, Kanter-Schlifke I, Dhondt J, Carmeliet P, Lambrechts D, Kokaia M.

PLoS One. 2012;7(7):e40535. doi: 10.1371/journal.pone.0040535. Epub 2012 Jul 12.

7.

Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy.

Verheyen A, Peeraer E, Nuydens R, Dhondt J, Poesen K, Pintelon I, Daniels A, Timmermans JP, Meert T, Carmeliet P, Lambrechts D.

Brain. 2012 Sep;135(Pt 9):2629-41. doi: 10.1093/brain/aws145. Epub 2012 Jun 25.

PMID:
22734125
8.

A novel 22bp deletion in a Tunisian phenylketonuria family.

Khemir S, Siala H, Azzouz H, Tebib N, Dhondt JL, Messaoud T, Abdelhak S, Ben Dridi MF, Kaabachi N.

Pathol Biol (Paris). 2012 Dec;60(6):e87-9. doi: 10.1016/j.patbio.2012.03.007. Epub 2012 May 7.

PMID:
22572109
9.

Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment.

Khemir S, El Asmi M, Sanhaji H, Feki M, Jemaa R, Tebib N, Dhondt JL, Ben Dridi MF, Mebazaa A, Kaabachi N.

Clin Neurol Neurosurg. 2011 Nov;113(9):727-30. doi: 10.1016/j.clineuro.2011.07.016. Epub 2011 Sep 8.

PMID:
21862209
10.

[Self assesment grid for pre-examination phase].

Dhondt JL, Lionne JP, Soubiran P, Szymanowicz A; membres du sous-groupe 1 pré-analytique.

Ann Biol Clin (Paris). 2010 Dec;68 Spec No 1:163-80. French.

PMID:
21613014
11.

[Guidelines concerning stat laboratory process].

Challine D, Dhondt JL, Szymanowicz A; membres du sous-groupe 1 pré-analytique.

Ann Biol Clin (Paris). 2010 Dec;68 Spec No 1:147-54. French.

PMID:
21613012
12.

[Management of pre-analytical nonconformities].

Berkane Z, Dhondt JL, Drouillard I, Flourié F, Giannoli JM, Houlbert C, Surgat P, Szymanowicz A; membres du sous-groupe 1 pré-analytique.

Ann Biol Clin (Paris). 2010 Dec;68 Spec No 1:131-45. French.

PMID:
21613011
13.

[Guidelines concerning sample reception and request recording of laboratory tests].

Bailly P, Dhondt JL, Drouard L, Houlbert C, Soubiran P, Szymanowicz A; membres du sous-groupe 1 pré-analytique.

Ann Biol Clin (Paris). 2010 Dec;68 Spec No 1:105-10. French.

PMID:
21613009
14.

[Guidelines relative to the collection and handling management of biological samples].

Barbier F, Berkane Z, Dehorne JP, Desch G, Dhondt JL, Drouillard I, Serre-Debeauvais F, Soubiran P, Surgat P, Szymanowicz A; membres du sous-groupe 1 pré-analytique.

Ann Biol Clin (Paris). 2010 Dec;68 Spec No 1:69-104. French.

PMID:
21613008
15.

Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons.

Dhondt J, Peeraer E, Verheyen A, Nuydens R, Buysschaert I, Poesen K, Van Geyte K, Beerens M, Shibuya M, Haigh JJ, Meert T, Carmeliet P, Lambrechts D.

FASEB J. 2011 May;25(5):1461-73. doi: 10.1096/fj.10-170944. Epub 2011 Jan 19.

16.

Microglial upregulation of progranulin as a marker of motor neuron degeneration.

Philips T, De Muynck L, Thu HN, Weynants B, Vanacker P, Dhondt J, Sleegers K, Schelhaas HJ, Verbeek M, Vandenberghe R, Sciot R, Van Broeckhoven C, Lambrechts D, Van Leuven F, Van Den Bosch L, Robberecht W, Van Damme P.

J Neuropathol Exp Neurol. 2010 Dec;69(12):1191-200. doi: 10.1097/NEN.0b013e3181fc9aea.

PMID:
21107132
17.

Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1.

Ruiz de Almodovar C, Coulon C, Salin PA, Knevels E, Chounlamountri N, Poesen K, Hermans K, Lambrechts D, Van Geyte K, Dhondt J, Dresselaers T, Renaud J, Aragones J, Zacchigna S, Geudens I, Gall D, Stroobants S, Mutin M, Dassonville K, Storkebaum E, Jordan BF, Eriksson U, Moons L, D'Hooge R, Haigh JJ, Belin MF, Schiffmann S, Van Hecke P, Gallez B, Vinckier S, Chédotal A, Honnorat J, Thomasset N, Carmeliet P, Meissirel C.

J Neurosci. 2010 Nov 10;30(45):15052-66. doi: 10.1523/JNEUROSCI.0477-10.2010.

18.

[Heel lance versus venepuncture in blood sampling for newborn screening].

Dhondt JL; Association française pour dépistage et prévention des handicaps de l'enfant (AFDPHE).

Arch Pediatr. 2010 Oct;17(10):1394-7. doi: 10.1016/j.arcped.2010.07.014. Epub 2010 Sep 16. French. No abstract available.

PMID:
20843671
19.

Expanded newborn screening: social and ethical issues.

Dhondt JL.

J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S211-7. doi: 10.1007/s10545-010-9138-y. Epub 2010 Jun 11. Review.

PMID:
20544288
20.

Lessons from 30 years of selective screening for tetrahydrobiopterin deficiency.

Dhondt JL.

J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S219-23. doi: 10.1007/s10545-010-9091-9. Epub 2010 May 11.

PMID:
20458544
21.

[Reliability of immunoturbidimetric urine albumin determination for normal and moderately high values].

Bezé F, Forzy G, Dhondt JL.

Ann Biol Clin (Paris). 2009 Nov-Dec;67(6):711-4. doi: 10.1684/abc.2009.0388. French.

22.

The XX International Congress of Zoology, 26-29 August 2008, Paris.

Jallon JM, Lafont R, dHondt JL, Deutsch J.

Integr Zool. 2009 Sep;4(3):257. doi: 10.1111/j.1749-4877.2009.00172.x. No abstract available.

23.

VEGF protects motor neurons against excitotoxicity by upregulation of GluR2.

Bogaert E, Van Damme P, Poesen K, Dhondt J, Hersmus N, Kiraly D, Scheveneels W, Robberecht W, Van Den Bosch L.

Neurobiol Aging. 2010 Dec;31(12):2185-91. doi: 10.1016/j.neurobiolaging.2008.12.007. Epub 2009 Jan 29.

PMID:
19185395
24.

[Prematurity and neonatal screening].

Dhondt JL.

Arch Pediatr. 2008 Jun;15 Suppl 1:S7-S11. doi: 10.1016/S0929-693X(08)73941-1. French.

PMID:
18822259
25.

Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.

Poesen K, Lambrechts D, Van Damme P, Dhondt J, Bender F, Frank N, Bogaert E, Claes B, Heylen L, Verheyen A, Raes K, Tjwa M, Eriksson U, Shibuya M, Nuydens R, Van Den Bosch L, Meert T, D'Hooge R, Sendtner M, Robberecht W, Carmeliet P.

J Neurosci. 2008 Oct 15;28(42):10451-9. doi: 10.1523/JNEUROSCI.1092-08.2008.

26.

[The future of neonatal screening programs].

Dhondt JL.

Arch Pediatr. 2008 Jun;15(5):769-71. doi: 10.1016/S0929-693X(08)71905-5. French. No abstract available.

PMID:
18582744
27.

Implementation of the French nationwide cystic fibrosis newborn screening program.

Munck A, Dhondt JL, Sahler C, Roussey M.

J Pediatr. 2008 Aug;153(2):228-33, 233.e1. doi: 10.1016/j.jpeds.2008.02.028. Epub 2008 Apr 18.

PMID:
18534227
28.

[Application of the uncertainty of measurement for PSA determination].

Tintillier-Colin V, Forzy G, Colin P, Dhondt JL.

Ann Biol Clin (Paris). 2007 Nov-Dec;65(6):685-7. French. No abstract available.

29.

First ISNS Reference Preparation for Neonatal Screening for thyrotropin, phenylalanine and 17alpha-hydroxyprogesterone in blood spots.

Elvers LH, Loeber JG, Dhondt JL, Fukushi M, Hannon WH, Torresani T, Webster D.

J Inherit Metab Dis. 2007 Aug;30(4):609. Epub 2007 Jun 14.

PMID:
17574536
30.

Neonatal screening: from the 'Guthrie age' to the 'genetic age'.

Dhondt JL.

J Inherit Metab Dis. 2007 Aug;30(4):418-22. Epub 2007 May 12.

PMID:
17505914
31.

[Interest of Prom-Test in the follow-up of premature rupture of membranes].

Forzy G, Denoit V, Dallemagne V, Dubois C, Delgranche A, Houzé D, Dhondt JL.

Ann Biol Clin (Paris). 2007 May-Jun;65(3):313-6. French.

32.

[Hyperhomocysteinaemia and type 2 diabetes].

Vangelder E, Delecourt F, Cardozo MB, Dhondt JL, Forzy G.

Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):485-9. French.

34.

[Severe hyperphosphatetemia].

Dieval F, Strozyk L, Vanderlinden T, Forzy G, Dhondt JL.

Ann Biol Clin (Paris). 2005 Jul-Aug;63(4):436. French. No abstract available.

PMID:
16104065
35.

[Sickle cell disease neonatal screening. First evaluation].

Mbodj M, Ndoye O, Diarra M, Mbaye BN, Sow Toure H, Diouf L, Gassama Seck S, Dhondt JL, Farriaux JP.

Dakar Med. 2003;48(3):202-5. French.

PMID:
15776632
37.

[Chief editor of a scientific journal... A risky profession?].

Dhondt JL.

Ann Biol Clin (Paris). 2004 May-Jun;62(3):251. French. No abstract available.

38.

Neonatal screening for cystic fibrosis: France rises to the challenge.

Farriaux JP, Vidailhet M, Briard ML, Belot V, Dhondt JL.

J Inherit Metab Dis. 2003;26(8):729-44.

PMID:
14739679
39.

[Good practices for the study of hemoglobin].

Bardakdjian-Michau J, Dhondt JL, Ducrocq R, Galactéros F, Guyard A, Huchet FX, Lahary A, Lena-Russo D, Maboudou P, North ML, Prehu C, Soummer AM, Verschelde M, Wajcman H; Groupe de travail SFBC << Recommandations dans le domaine des diagnostics des hémoglobinopathies >>.

Ann Biol Clin (Paris). 2003 Jul-Aug;61(4):401-9. French. Erratum in: Ann Biol Clin (Paris). 2003 Sep-Oct;61(5):588.

40.

[Use of formulas for calculating serum osmolality].

Forzy G, Quelquejay J, Dhondt JL.

Ann Biol Clin (Paris). 2003 Jan-Feb;61(1):103-5. French.

41.

[Usual values for 5-hydroxy-indol acetic acid and homovanillic acid in cerebrospinal fluid].

Dhondt JL, Forzy G.

Ann Biol Clin (Paris). 2003 Jan-Feb;61(1):69-75. French.

42.

[Cannabis and nifluril].

Forzy G, Spyckerelle C, Scalber M, Lhermitte M, Dhondt JL.

Ann Biol Clin (Paris). 2002 Nov-Dec;60(6):745-6. French. No abstract available.

43.

[Screening of tetrahydrobiopterin deficiency among hyperphenylalaninemic patients].

Dhondt JL, Hayte JM.

Ann Biol Clin (Paris). 2002 Mar-Apr;60(2):165-71. French.

44.

[The importance of the summary].

Dhondt JL.

Ann Biol Clin (Paris). 2002 Mar-Apr;60(2):129. French. No abstract available.

45.

[Evaluation of the BD QuikHeel device for capillary blood sampling in neonates].

Dhondt JL, Oosterlinck E, Forzy G.

Ann Biol Clin (Paris). 2001 Sep-Oct;59(5):647-50. French. No abstract available.

46.

[The missing link: quality in the identification and preanalytic phase].

Dhondt JL.

Ann Biol Clin (Paris). 2001 Mar-Apr;59(2):231-2. French. No abstract available.

47.
48.

[But what does the editorial board do?].

Dhondt JL.

Ann Biol Clin (Paris). 2000 Nov-Dec;58(6):657-8. French. No abstract available.

49.

["Hemolyzed" blood sample].

Dhondt J, Hayte J, Demouveaux A.

Ann Biol Clin (Paris). 2000 Sep-Oct;58(5):639. French. No abstract available.

50.

En juin dernier

Dhondt J.

Ann Biol Clin (Paris). 2000 Sep;58(5):525. French. No abstract available.

Supplemental Content

Loading ...
Support Center